The advent of a growing number of animal and cell-based models that reproduce the human disease pathology has improved our understanding of disease mechanisms and the cellular pathways underlying PT dysfunction and renal Fanconi syndrome, ultimately accelerating the discovery and development of promising new therapeutic approaches. This evidence concerns the gene F2 and adult Fanconi syndrome.